News About: Goverment
Two new drugs to be licensed during this year
This year will witness another market authorization of two new drugs developed by domestic pharmaceutical firms Gu-ju's antiarthritic agent Apitoxin inj. and LGCI's quinolone antibiotitc Factive, following the alread...
Makers direct supply possible when in calamity or wholesaler's strikes.
The MOHW announced on June 20 that the pharmaceutical manufacturers are allowed to supply their products directly to general hospitals in the event of natural disasters or of the wholesaler's group strikes, by revisin...
Prices of 800 insurance drugs likely to fall by 9.5 percent
Business sources say that the domestic pharmaceutical industry is at pains to cope with the consecutive government measures to reduce the insurance prices of another 800 items in a 9.5 percent level, following the pri...
Prescription ratios of high-priced drugs are again increasing up to 50 percent level
The doctor's prescription of high-priced drugs are again getting its momentum, thus putting the national health insurance finance in turmoil, according to data released by the Ministry of Health and Welfare.
The MO...
Bottom price system enforcement to curb.
The Deregulation Reform Commission (DRC) decided to review the Rock Bottom Pricing system for the NHI drugs after judgment of its restrictive elements.
The MOHW drafted a provision titled "the Rock Bottom Pricing...
Pharmaceutical raw material report system to apply for new items.
The pharmaceutical raw material report system shall be enforced for the new chemical entity authorized by the KFDA from July 1 this year according to the KFDA's guideline of the pharmaceutical raw material report.
...
KFDA to delay the submission of BGMP certificate for imported pharmaceutical bulks
The Korea Food and Drug Administration (KFDA) said it will delay the submission of BGMP certificate for imported pharmaceutical bulks until December 2002 by extending a 6-month grace period.
The KFDA said that if a...
MOHW to lower 782 insurance drugs below three percent
The Ministry of Health and Welfare has announced a total of 782 insurance drugs (131 pharmaceutical firms), which are being sold at more reduced prices than the reported ceiling prices or in the form of extra drug, wi...
Waiver of equivalence tests for some ingredients eyed
The Korea Food and Drug Administration (KFDA) says it has recently drafted a guideline to waiver the bioeqivalence tests on some ingredients used for liquid-form preparations (such as syrups), digestive enzymes, injec...
More efficient advance strategy for Chinese market urged
Yeo Hwan-jin, director of MKP & Tec Co., explained more efficient advance strategy for Chinese market at a recent seminar of the development of drug intermediates and pharmaceutical bulk drugs at on May 12 under the a...
